<?xml version="1.0" encoding="utf-8"?>
<!--<!DOCTYPE converted-article PUBLIC "-//ES//DTD journal article DTD version 4.5.2//EN//XML" "art452.dtd" [
<!ENTITY gr1 SYSTEM "gr1" NDATA IMAGE><!ENTITY gr2 SYSTEM "gr2" NDATA IMAGE>]>
-->
<converted-article version="4.5.2" docsubtype="fla" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd">
    <item-info>
        <jid>IJCA</jid>
        <aid>3755</aid>
        <ce:pii>S0167-5273(99)00147-3</ce:pii>
        <ce:doi>10.1016/S0167-5273(99)00147-3</ce:doi>
        <ce:copyright type="full-transfer" year="1999">Elsevier Science Ireland Ltd</ce:copyright>
    </item-info>
    <ce:floats>
        <ce:figure id="FIG1">
            <ce:label>Fig. 1</ce:label>
            <ce:caption>
                <ce:simple-para>Kaplan&#x2013;Meier event free survival curve for cardiac death in patients with (<ce:italic>n</ce:italic>=10) and without silent ischemia (<ce:italic>n</ce:italic>=87)
                    on Holter-monitoring after thrombolysis and early coronary intervention for acute myocardial infarction.</ce:simple-para>
            </ce:caption>
            <ce:link locator="gr1"/>
        </ce:figure>
        <ce:figure id="FIG2">
            <ce:label>Fig. 2</ce:label>
            <ce:caption>
                <ce:simple-para>Kaplan&#x2013;Meier event free survival curve for all cardiac events (cardiac death, nonfatal reinfarction emergency percutaneous transluminal coronary
                    angioplasty/coronary artery bypass grafting) in patients with (<ce:italic>n</ce:italic>=10) and without silent ischemia (<ce:italic>n</ce:italic>=87) on Holter-monitoring after
                    thrombolysis and early coronary intervention for acute myocardial infarction.</ce:simple-para>
            </ce:caption>
            <ce:link locator="gr2"/>
        </ce:figure>
        <ce:table id="TBL1" colsep="0" rowsep="0" frame="topbot">
            <ce:label>Table 1</ce:label>
            <ce:caption>
                <ce:simple-para>Clinical baseline characteristics of the patients</ce:simple-para>
            </ce:caption>
            <tgroup cols="5">
                <colspec colname="col1" colsep="0"/>
                <colspec colname="col2" colsep="0"/>
                <colspec colname="col3" colsep="0"/>
                <colspec colname="col4" colsep="0"/>
                <colspec colname="col5" colsep="0"/>
                <thead>
                    <row>
                        <entry>Characteristics</entry>
                        <entry>All Patients</entry>
                        <entry>Group A</entry>
                        <entry>Group B</entry>
                        <entry><ce:italic>p</ce:italic>-Value</entry>
                    </row>
                    <row rowsep="1">
                        <entry/>
                        <entry>(<ce:italic>n</ce:italic>=97)</entry>
                        <entry>(<ce:italic>n</ce:italic>=10)</entry>
                        <entry>(<ce:italic>n</ce:italic>=87)</entry>
                        <entry/>
                    </row>
                </thead>
                <tbody>
                    <row>
                        <entry align="char" char="."><ce:vsp sp="1"/>Mean age [years]</entry>
                        <entry align="char" char=".">57&#x00B1;9</entry>
                        <entry align="char" char=".">55&#x00B1;11</entry>
                        <entry align="char" char=".">57&#x00B1;9</entry>
                        <entry align="char" char=".">NS</entry>
                    </row>
                    <row>
                        <entry>Range</entry>
                        <entry align="char" char=".">21&#x2013;75</entry>
                        <entry align="char" char=".">39&#x2013;73</entry>
                        <entry align="char" char=".">21&#x2013;75</entry>
                        <entry/>
                    </row>
                    <row>
                        <entry>Male sex (%)</entry>
                        <entry align="char" char=".">85 (88)</entry>
                        <entry align="char" char=".">9 (90)</entry>
                        <entry align="char" char=".">76 (87)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry><ce:vsp sp="1"/>Infarct site</entry>
                        <entry/>
                        <entry/>
                        <entry/>
                        <entry/>
                    </row>
                    <row>
                        <entry><ce:vsp sp="0.5"/>Anterior (%)</entry>
                        <entry align="char" char=".">43 (44)</entry>
                        <entry align="char" char=".">5 (50)</entry>
                        <entry align="char" char=".">38 (44)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Inferior (%)</entry>
                        <entry align="char" char=".">54 (56)</entry>
                        <entry align="char" char=".">5 (50)</entry>
                        <entry align="char" char=".">49 (56)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry><ce:vsp sp="1"/>Peak-creatine</entry>
                        <entry/>
                        <entry/>
                        <entry/>
                        <entry/>
                    </row>
                    <row>
                        <entry><ce:vsp sp="0.5"/>kinase [U/l]</entry>
                        <entry align="char" char=".">1077&#x00B1;805</entry>
                        <entry align="char" char=".">1677&#x00B1;1035</entry>
                        <entry align="char" char=".">1008&#x00B1;751</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry><ce:vsp sp="1"/>History</entry>
                        <entry/>
                        <entry/>
                        <entry/>
                        <entry/>
                    </row>
                    <row>
                        <entry><ce:vsp sp="0.5"/>Previous MI<ce:cross-ref refid="TBLFN1A"><ce:sup>a</ce:sup></ce:cross-ref> (%)</entry>
                        <entry align="char" char=".">20 (21)</entry>
                        <entry align="char" char=".">4 (40)</entry>
                        <entry align="char" char=".">16 (18)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Smoker (%)</entry>
                        <entry align="char" char=".">77 (80)</entry>
                        <entry align="char" char=".">10 (100)</entry>
                        <entry align="char" char=".">67 (77)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Hypertension (%)</entry>
                        <entry align="char" char=".">48 (49)</entry>
                        <entry align="char" char=".">5 (50)</entry>
                        <entry align="char" char=".">43 (49)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Hyperlipidemia (%)</entry>
                        <entry align="char" char=".">38 (39)</entry>
                        <entry align="char" char=".">4 (40)</entry>
                        <entry align="char" char=".">34 (39)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Diabetes (%)</entry>
                        <entry align="char" char=".">16 (16)</entry>
                        <entry align="char" char=".">1 (10)</entry>
                        <entry align="char" char=".">15 (17)</entry>
                        <entry>NS</entry>
                    </row>
                </tbody>
            </tgroup>
            <ce:table-footnote id="TBLFN1A">
                <ce:label>a</ce:label>
                <ce:note-para>MI=myocardial infarction.</ce:note-para>
            </ce:table-footnote>
        </ce:table>
        <ce:table id="TBL2" colsep="0" rowsep="0" frame="topbot">
            <ce:label>Table 2</ce:label>
            <ce:caption>
                <ce:simple-para>Angiographic findings and frequency of percutaneous transluminal coronary angioplasty</ce:simple-para>
            </ce:caption>
            <tgroup cols="5">
                <colspec colname="col1" colsep="0"/>
                <colspec colname="col2" colsep="0"/>
                <colspec colname="col3" colsep="0"/>
                <colspec colname="col4" colsep="0"/>
                <colspec colname="col5" colsep="0"/>
                <thead>
                    <row>
                        <entry/>
                        <entry>All patients</entry>
                        <entry>Group A</entry>
                        <entry>Group B</entry>
                        <entry><ce:italic>p</ce:italic>-Value</entry>
                    </row>
                    <row rowsep="1">
                        <entry/>
                        <entry>(<ce:italic>n</ce:italic>=97)</entry>
                        <entry>(<ce:italic>n</ce:italic>=10)</entry>
                        <entry>(<ce:italic>n</ce:italic>=87)</entry>
                        <entry/>
                    </row>
                </thead>
                <tbody>
                    <row>
                        <entry>Extent of coronary heart disease</entry>
                        <entry/>
                        <entry/>
                        <entry/>
                        <entry/>
                    </row>
                    <row>
                        <entry><ce:vsp sp="1"/>0-vessel (%)</entry>
                        <entry align="char" char=".">27 (28)</entry>
                        <entry align="char" char=".">1 (10)</entry>
                        <entry align="char" char=".">26 (30)</entry>
                        <entry align="char" char=".">NS</entry>
                    </row>
                    <row>
                        <entry>1-vessel (%)</entry>
                        <entry align="char" char=".">37 (38)</entry>
                        <entry align="char" char=".">4 (40)</entry>
                        <entry align="char" char=".">33 (38)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>2-vessel (%)</entry>
                        <entry align="char" char=".">23 (24)</entry>
                        <entry align="char" char=".">2 (20)</entry>
                        <entry align="char" char=".">21 (24)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>3-vessel (%)</entry>
                        <entry align="char" char=".">10 (10)</entry>
                        <entry align="char" char=".">3 (30)</entry>
                        <entry align="char" char=".">7 (8)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry><ce:vsp sp="1"/>LVEF<ce:cross-ref refid="TBLFN2A"><ce:sup>a</ce:sup></ce:cross-ref> (%)</entry>
                        <entry align="char" char=".">55&#x00B1;15</entry>
                        <entry align="char" char=".">47&#x00B1;15*</entry>
                        <entry align="char" char=".">56&#x00B1;15*</entry>
                        <entry align="char" char=".">0.07*</entry>
                    </row>
                    <row>
                        <entry>LVEF&#x003C;40% (%)</entry>
                        <entry align="char" char=".">19 (20)</entry>
                        <entry align="char" char=".">4 (40)</entry>
                        <entry align="char" char=".">15 (17)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry><ce:vsp sp="1"/>Successful PTCA<ce:cross-ref refid="TBLFN2B"><ce:sup>b</ce:sup></ce:cross-ref> (%)</entry>
                        <entry align="char" char=".">57 (59)</entry>
                        <entry align="char" char=".">6 (60)</entry>
                        <entry align="char" char=".">51 (59)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>No PTCA (%)</entry>
                        <entry align="char" char=".">40 (41)</entry>
                        <entry align="char" char=".">4 (40)</entry>
                        <entry align="char" char=".">36 (41)</entry>
                        <entry>NS</entry>
                    </row>
                </tbody>
            </tgroup>
            <ce:table-footnote id="TBLFN2A">
                <ce:label>a</ce:label>
                <ce:note-para>LVEF=left ventricular ejection fraction.</ce:note-para>
            </ce:table-footnote>
            <ce:table-footnote id="TBLFN2B">
                <ce:label>b</ce:label>
                <ce:note-para>PTCA=percutaneous transluminal coronary angioplasty.</ce:note-para>
            </ce:table-footnote>
        </ce:table>
        <ce:table id="TBL3" colsep="0" rowsep="0" frame="topbot">
            <ce:label>Table 3</ce:label>
            <ce:caption>
                <ce:simple-para>Results of the Holter-monitoring</ce:simple-para>
            </ce:caption>
            <tgroup cols="3">
                <colspec colname="col1" colsep="0"/>
                <colspec colname="col2" colsep="0"/>
                <colspec colname="col3" colsep="0"/>
                <thead>
                    <row>
                        <entry/>
                        <entry>Silent ST-episodes</entry>
                        <entry>No ST-episodes</entry>
                    </row>
                    <row rowsep="1">
                        <entry/>
                        <entry>(<ce:italic>n</ce:italic>=10)</entry>
                        <entry>(<ce:italic>n</ce:italic>=87)</entry>
                    </row>
                </thead>
                <tbody>
                    <row>
                        <entry align="char" char="."><ce:vsp sp="0.5"/>Duration of HM<ce:cross-ref refid="TBLFN3A"><ce:sup>a</ce:sup></ce:cross-ref> [h]</entry>
                        <entry>23&#x00B1;1</entry>
                        <entry>22&#x00B1;2</entry>
                    </row>
                    <row>
                        <entry>Delay of HM from MI<ce:cross-ref refid="TBLFN3B"><ce:sup>b</ce:sup></ce:cross-ref> [h]</entry>
                        <entry>43&#x00B1;14</entry>
                        <entry>39&#x00B1;11</entry>
                    </row>
                    <row>
                        <entry>Total number [n]</entry>
                        <entry>42</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry>Mean&#x00B1;SD<ce:cross-ref refid="TBLFN3C"><ce:sup>c</ce:sup></ce:cross-ref></entry>
                        <entry>4.2&#x00B1;4.9</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry>Range</entry>
                        <entry>1&#x2013;18</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry>Total duration [min]</entry>
                        <entry>401</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry>Mean&#x00B1;SD</entry>
                        <entry>40&#x00B1;48</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry>Range</entry>
                        <entry>4.5&#x2013;138</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry><ce:vsp sp="0.5"/>Duration/episode [min]</entry>
                        <entry/>
                        <entry/>
                    </row>
                    <row>
                        <entry>Mean&#x00B1;SD</entry>
                        <entry>9.5&#x00B1;9.7</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry>Range</entry>
                        <entry>1&#x2013;36</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry><ce:vsp sp="0.5"/>Average ST-deviation [&#x03BC;V]</entry>
                        <entry/>
                        <entry/>
                    </row>
                    <row>
                        <entry>Mean&#x00B1;SD</entry>
                        <entry>140&#x00B1;19</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry>Range</entry>
                        <entry>108&#x2013;163</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry><ce:vsp sp="0.5"/>Maximal ST-deviation [&#x03BC;V]</entry>
                        <entry/>
                        <entry/>
                    </row>
                    <row>
                        <entry>Mean&#x00B1;SD</entry>
                        <entry>183&#x00B1;44</entry>
                        <entry>0</entry>
                    </row>
                    <row>
                        <entry>Range</entry>
                        <entry>110&#x2013;330</entry>
                        <entry>0</entry>
                    </row>
                </tbody>
            </tgroup>
            <ce:table-footnote id="TBLFN3A">
                <ce:label>a</ce:label>
                <ce:note-para>HM=Holter-monitoring.</ce:note-para>
            </ce:table-footnote>
            <ce:table-footnote id="TBLFN3B">
                <ce:label>b</ce:label>
                <ce:note-para>MI=myocardial infarction.</ce:note-para>
            </ce:table-footnote>
            <ce:table-footnote id="TBLFN3C">
                <ce:label>c</ce:label>
                <ce:note-para>SD=standard deviation.</ce:note-para>
            </ce:table-footnote>
        </ce:table>
        <ce:table id="TBL4" colsep="0" rowsep="0" frame="topbot">
            <ce:label>Table 4</ce:label>
            <ce:caption>
                <ce:simple-para>Cardiac events during in-hospital phase and long-term follow-up<ce:cross-ref refid="TBLFN4A"><ce:sup>a</ce:sup></ce:cross-ref></ce:simple-para>
            </ce:caption>
            <tgroup cols="5">
                <colspec colname="col1" colsep="0"/>
                <colspec colname="col2" colsep="0"/>
                <colspec colname="col3" colsep="0"/>
                <colspec colname="col4" colsep="0"/>
                <colspec colname="col5" colsep="0"/>
                <thead>
                    <row>
                        <entry/>
                        <entry>All patients</entry>
                        <entry>Group A</entry>
                        <entry>Group B</entry>
                        <entry><ce:italic>p</ce:italic>-</entry>
                    </row>
                    <row rowsep="1">
                        <entry/>
                        <entry>(<ce:italic>n</ce:italic>=97)</entry>
                        <entry>(<ce:italic>n</ce:italic>=10)</entry>
                        <entry>(<ce:italic>n</ce:italic>=87)</entry>
                        <entry>Value</entry>
                    </row>
                    <row>
                        <entry namest="col1" nameend="col5">
                            <ce:italic>In-hospital phase</ce:italic>
                        </entry>
                    </row>
                </thead>
                <tbody>
                    <row>
                        <entry align="char" char=".">In-hospital phase [days]</entry>
                        <entry>27&#x00B1;3</entry>
                        <entry>27&#x00B1;2</entry>
                        <entry>27&#x00B1;3</entry>
                        <entry align="char" char=".">NS</entry>
                    </row>
                    <row>
                        <entry>Cardiac death (%)</entry>
                        <entry><ce:hsp sp="0.5"/>2 (2)</entry>
                        <entry><ce:hsp sp="0.5"/>1 (10)</entry>
                        <entry><ce:hsp sp="0.5"/>1 (1)</entry>
                        <entry align="char" char=".">&#x003C;0.05*</entry>
                    </row>
                    <row>
                        <entry>Nonfatal reinfarction (%)</entry>
                        <entry><ce:hsp sp="0.5"/>1 (1)</entry>
                        <entry><ce:hsp sp="0.5"/>0 (0)</entry>
                        <entry><ce:hsp sp="0.5"/>1 (1)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Emergency PTCA/CABG (%)</entry>
                        <entry><ce:hsp sp="0.5"/>0 (0)</entry>
                        <entry><ce:hsp sp="0.5"/>0 (0)</entry>
                        <entry><ce:hsp sp="0.5"/>0 (0)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>All cardiac events (%)</entry>
                        <entry><ce:hsp sp="0.5"/>3 (3)</entry>
                        <entry><ce:hsp sp="0.5"/>1 (10)</entry>
                        <entry><ce:hsp sp="0.5"/>2 (2)</entry>
                        <entry>NS</entry>
                    </row>
                    <row rowsep="1">
                        <entry>Elective PTCA/CABG (%)</entry>
                        <entry>26 (27)</entry>
                        <entry><ce:hsp sp="0.5"/>2 (20)</entry>
                        <entry>24 (28)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry/>
                        <entry>All patients</entry>
                        <entry>Group A</entry>
                        <entry>Group B</entry>
                        <entry><ce:italic>p</ce:italic>-</entry>
                    </row>
                    <row rowsep="1">
                        <entry/>
                        <entry>(<ce:italic>n</ce:italic>=94) <ce:sup loc="pre">&#x2020;</ce:sup></entry>
                        <entry>(<ce:italic>n</ce:italic>=8) <ce:sup loc="pre">&#x2020;</ce:sup></entry>
                        <entry>(<ce:italic>n</ce:italic>=86) <ce:sup loc="pre">&#x2020;</ce:sup></entry>
                        <entry>Value</entry>
                    </row>
                    <row>
                        <entry namest="col1" nameend="col5">
                            <ce:italic>Long-term follow-up</ce:italic>
                        </entry>
                    </row>
                    <row>
                        <entry>Follow-up [days]</entry>
                        <entry>923&#x00B1;389</entry>
                        <entry>727&#x00B1;608</entry>
                        <entry>944&#x00B1;354</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Cardiac death (%)</entry>
                        <entry><ce:hsp sp="1"/>6 (6)</entry>
                        <entry><ce:hsp sp="1"/>2 (25)</entry>
                        <entry><ce:hsp sp="1"/>4 (5)</entry>
                        <entry align="char" char=".">&#x003C;0.02*</entry>
                    </row>
                    <row>
                        <entry>Nonfatal reinfarction (%)</entry>
                        <entry><ce:hsp sp="1"/>2 (2)</entry>
                        <entry><ce:hsp sp="1"/>0 (0)</entry>
                        <entry><ce:hsp sp="1"/>2 (2)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Emergency PTCA/CABG (%)</entry>
                        <entry><ce:hsp sp="1"/>8 (9)</entry>
                        <entry><ce:hsp sp="1"/>0 (0)</entry>
                        <entry><ce:hsp sp="1"/>8 (9)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>All cardiac events (%)</entry>
                        <entry><ce:hsp sp="0.5"/>16 (17)</entry>
                        <entry><ce:hsp sp="1"/>2 (25)</entry>
                        <entry><ce:hsp sp="0.5"/>14 (16)</entry>
                        <entry>NS</entry>
                    </row>
                    <row rowsep="1">
                        <entry>Elective PTCA/CABG (%)</entry>
                        <entry><ce:hsp sp="0.5"/>15 (16)</entry>
                        <entry><ce:hsp sp="1"/>1 (13)</entry>
                        <entry><ce:hsp sp="0.5"/>14 (16)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry/>
                        <entry>All patients</entry>
                        <entry>Group A</entry>
                        <entry>Group B</entry>
                        <entry><ce:italic>p</ce:italic>-Value</entry>
                    </row>
                    <row rowsep="1">
                        <entry/>
                        <entry>(<ce:italic>n</ce:italic>=97)</entry>
                        <entry>(<ce:italic>n</ce:italic>=10)</entry>
                        <entry>(<ce:italic>n</ce:italic>=87)</entry>
                        <entry/>
                    </row>
                    <row>
                        <entry namest="col1" nameend="col5">
                            <ce:italic>In-hospital phase and long-term follow-up</ce:italic>
                        </entry>
                    </row>
                    <row>
                        <entry>Total follow-up period [days]</entry>
                        <entry>950&#x00B1;392</entry>
                        <entry>754&#x00B1;610</entry>
                        <entry>973&#x00B1;357</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Cardiac death (%)</entry>
                        <entry><ce:hsp sp="1"/>8 (8)</entry>
                        <entry><ce:hsp sp="1"/>3 (30)</entry>
                        <entry><ce:hsp sp="1"/>5 (6)</entry>
                        <entry align="char" char=".">&#x003C;0.01<ce:sup>*</ce:sup></entry>
                    </row>
                    <row>
                        <entry>Nonfatal reinfarction (%)</entry>
                        <entry><ce:hsp sp="1"/>3 (3)</entry>
                        <entry><ce:hsp sp="1"/>0 (0)</entry>
                        <entry><ce:hsp sp="1"/>3 (3)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Emergency PTCA/CABG (%)</entry>
                        <entry><ce:hsp sp="1"/>8 (8)</entry>
                        <entry><ce:hsp sp="1"/>0 (0)</entry>
                        <entry><ce:hsp sp="1"/>8 (9)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>All cardiac events (%)</entry>
                        <entry><ce:hsp sp="0.5"/>19 (20)</entry>
                        <entry><ce:hsp sp="1"/>3 (30)</entry>
                        <entry><ce:hsp sp="0.5"/>16 (18)</entry>
                        <entry>NS</entry>
                    </row>
                    <row>
                        <entry>Elective PTCA/CABG (%)</entry>
                        <entry><ce:hsp sp="0.5"/>41 (42)</entry>
                        <entry><ce:hsp sp="1"/>3 (30)</entry>
                        <entry><ce:hsp sp="0.5"/>38 (44)</entry>
                        <entry>NS</entry>
                    </row>
                </tbody>
            </tgroup>
            <ce:table-footnote id="TBLFN4A">
                <ce:label>a</ce:label>
                <ce:note-para>CABG=coronary artery bypass grafting; PTCA=percutaneous transluminal coronary angioplasty. * by log-rank test (Cox&#x2013;Mantel); &#x2020;: 1 patient of group A died of
                    noncardiac cause during the in-hospital phase, during the long-term follow-up 1 patient each of group A and B died of noncardiac cause.</ce:note-para>
            </ce:table-footnote>
        </ce:table>
        <ce:table id="TBL5" colsep="0" rowsep="0" frame="topbot">
            <ce:label>Table 5</ce:label>
            <ce:caption>
                <ce:simple-para>Predictive values of silent ischemia and LVEF&#x003C;40% for cardiac mortality</ce:simple-para>
            </ce:caption>
            <tgroup cols="5">
                <colspec colname="col1" colsep="0"/>
                <colspec colname="col2" colsep="0"/>
                <colspec colname="col3" colsep="0"/>
                <colspec colname="col4" colsep="0"/>
                <colspec colname="col5" colsep="0"/>
                <thead>
                    <row>
                        <entry>Parameters</entry>
                        <entry>Sensitivity</entry>
                        <entry>Specificity</entry>
                        <entry>Positive predictive</entry>
                        <entry>Negative predictive</entry>
                    </row>
                    <row>
                        <entry/>
                        <entry>(%)</entry>
                        <entry>(%)</entry>
                        <entry>accuracy</entry>
                        <entry>accuracy</entry>
                    </row>
                    <row rowsep="1">
                        <entry/>
                        <entry/>
                        <entry/>
                        <entry>(%)</entry>
                        <entry>(%)</entry>
                    </row>
                </thead>
                <tbody>
                    <row>
                        <entry>Silent ischemia</entry>
                        <entry>38</entry>
                        <entry align="char" char=".">92</entry>
                        <entry align="char" char=".">30</entry>
                        <entry align="char" char=".">94</entry>
                    </row>
                    <row>
                        <entry>LVEF<ce:cross-ref refid="TBLFN5A"><ce:sup>a</ce:sup></ce:cross-ref> &#x003C;40%</entry>
                        <entry align="char" char=".">75</entry>
                        <entry align="char" char=".">85</entry>
                        <entry align="char" char=".">32</entry>
                        <entry align="char" char=".">97</entry>
                    </row>
                    <row>
                        <entry>Silent ischemia</entry>
                        <entry/>
                        <entry/>
                        <entry/>
                        <entry/>
                    </row>
                    <row>
                        <entry>and LVEF &#x003C;40%</entry>
                        <entry align="char" char=".">38</entry>
                        <entry align="char" char=".">98</entry>
                        <entry align="char" char=".">75</entry>
                        <entry align="char" char=".">95</entry>
                    </row>
                </tbody>
            </tgroup>
            <ce:table-footnote id="TBLFN5A">
                <ce:label>a</ce:label>
                <ce:note-para>LVEF=left ventricular ejection fraction.</ce:note-para>
            </ce:table-footnote>
        </ce:table>
    </ce:floats>
    <head>
        <ce:title>Three-year follow-up of patients with silent ischemia in the subacute phase of myocardial infarction after thrombolysis and early coronary intervention</ce:title>
        <ce:author-group>
            <ce:author>
                <ce:given-name>Ulrich</ce:given-name>
                <ce:surname>Lotze</ce:surname>
                <ce:degrees>MD</ce:degrees>
                <ce:cross-ref refid="AFF1">
                    <ce:sup>a</ce:sup>
                </ce:cross-ref>
                <ce:cross-ref refid="CORR1">*</ce:cross-ref>
            </ce:author>
            <ce:author>
                <ce:given-name>Cem</ce:given-name>
                <ce:surname>&#x00D6;zbek</ce:surname>
                <ce:degrees>MD</ce:degrees>
                <ce:cross-ref refid="AFF2">
                    <ce:sup>b</ce:sup>
                </ce:cross-ref>
            </ce:author>
            <ce:author>
                <ce:given-name>Ulrich</ce:given-name>
                <ce:surname>Gerk</ce:surname>
                <ce:degrees>MD</ce:degrees>
                <ce:cross-ref refid="AFF3">
                    <ce:sup>c</ce:sup>
                </ce:cross-ref>
            </ce:author>
            <ce:author>
                <ce:given-name>Holger</ce:given-name>
                <ce:surname>Kaufmann</ce:surname>
                <ce:degrees>MD</ce:degrees>
                <ce:cross-ref refid="AFF3">
                    <ce:sup>c</ce:sup>
                </ce:cross-ref>
            </ce:author>
            <ce:author>
                <ce:given-name>Semi</ce:given-name>
                <ce:surname>Sen</ce:surname>
                <ce:degrees>MD</ce:degrees>
                <ce:cross-ref refid="AFF4">
                    <ce:sup>d</ce:sup>
                </ce:cross-ref>
            </ce:author>
            <ce:author>
                <ce:given-name>Hans</ce:given-name>
                <ce:surname>Reiner Figulla</ce:surname>
                <ce:degrees>MD</ce:degrees>
                <ce:cross-ref refid="AFF1">
                    <ce:sup>a</ce:sup>
                </ce:cross-ref>
            </ce:author>
            <ce:affiliation id="AFF1">
                <ce:label>a</ce:label>
                <ce:textfn>Department of Internal Medicine III (Cardiology, Angiology, Intensive Care Medicine), Hospital of Friedrich-Schiller-University, D-07740 Jena, Germany</ce:textfn>
            </ce:affiliation>
            <ce:affiliation id="AFF2">
                <ce:label>b</ce:label>
                <ce:textfn>Department of Cardiology, Distict Hospital V&#x00F6;lklingen, D-66333 V&#x00F6;lklingen, Germany</ce:textfn>
            </ce:affiliation>
            <ce:affiliation id="AFF3">
                <ce:label>c</ce:label>
                <ce:textfn>Department of Internal Medicine III (Cardiology, Angiology), University of Saarland, D-66421 Homburg/Saar, Germany</ce:textfn>
            </ce:affiliation>
            <ce:affiliation id="AFF4">
                <ce:label>d</ce:label>
                <ce:textfn>Department of Internal Medicine, Community Hospital Frankfurt/H&#x00F6;chst, D-65929, Frankfurt/Main, Germany</ce:textfn>
            </ce:affiliation>
            <ce:correspondence id="CORR1">
                <ce:label>*</ce:label>
                <ce:text>Corresponding author. Corresponding address. Klinikum der Friedrich-Schiller-Universit&#x00E4;t, Innere Medizin III, Erlanger Allee 101, D- 07740 Jena, Germany. Tel.:
                    +49-3641-939-360; fax: +49-3641-939-363</ce:text>
            </ce:correspondence>
        </ce:author-group>
        <ce:date-received day="8" month="6" year="1999"/>
        <ce:date-accepted day="6" month="8" year="1999"/>
        <ce:abstract>
            <ce:section-title>Abstract</ce:section-title>
            <ce:abstract-sec>
                <ce:simple-para>In order to assess the prognostic value of silent myocardial ischemia in acute myocardial infarction after thrombolysis and early coronary angiography (14&#x2013;48 h
                    after start of thrombolysis) including percutaneous transluminal coronary angioplasty, if indicated, 126 patients underwent 24 h-Holter-monitoring in the early postinfarction
                    period. The 24 h-Holter-recording was initiated directly after early coronary intervention (40&#x00B1;11 h after onset of symptoms). Of the 126 patients initially eligible for the
                    study 29 had to be excluded from further analysis for clinical or methodical reasons. Of the remaining 97 patients, 10 (10%) had silent ischemia (group A) and 87/97 (90%) patients
                    showed no significant ST-segment alterations. Both groups did not significantly differ from each other with regard to baseline clinical characteristics, severity of coronary artery
                    disease and frequency of successful percutaneous transluminal coronary angioplasty. The left ventricular ejection fraction showed a trend towards lower values in patients with than
                    in those without silent ischemia (47&#x00B1;15% vs. 55&#x00B1;13%, <ce:italic>p</ce:italic>=0.07). When both silent ischemia and left ventricular ejection fraction &#x003C;40% were
                    present, a subset of patients at high risk for cardiac death could be identified (specificity: 98%, positive predictive accuracy: 75%). By Kaplan&#x2013;Meier analysis,
                    significantly more cardiac deaths occurred in group A than in group B (30% vs. 6%, <ce:italic>p</ce:italic>&#x003C;0.01) during the three-year follow-up (950&#x00B1;392 days) after
                    acute myocardial infarction. Regarding the cardiac events during long-term follow-up (emergency percutaneous transluminal coronary angioplasty, coronary artery bypass grafting,
                    non-fatal reinfarction, and cardiac death) there was no significant difference between both groups (30% vs. 18%, NS). In conclusion, Holter monitor-detected silent ischemia in the
                    subacute phase of myocardial infarctionI after thrombolysis followed by early delayed coronary intervention occurs in 10% of the patients indicating either a residual ischemia in
                    the infarcted zone despite a combined reperfusion strategy or a remote ischemic potential in case of multivessel disease. In this small selected group of infarct patients too,
                    silent ischemia is to be considered as an important non-invasive parameter to predict cardiac death during long-term follow-up and provides valuable complementary information to
                    left ventricular dysfunction, a well established prognostic marker in the postinfarction period.</ce:simple-para>
            </ce:abstract-sec>
        </ce:abstract>
        <ce:keywords>
            <ce:section-title>Keywords</ce:section-title>
            <ce:keyword>
                <ce:text>Acute myocardial infarction</ce:text>
            </ce:keyword>
            <ce:keyword>
                <ce:text>Thrombolysis</ce:text>
            </ce:keyword>
            <ce:keyword>
                <ce:text>Early coronary angiography</ce:text>
            </ce:keyword>
            <ce:keyword>
                <ce:text>Percutaneous transluminal coronary angioplasty</ce:text>
            </ce:keyword>
            <ce:keyword>
                <ce:text>Silent ischemia</ce:text>
            </ce:keyword>
            <ce:keyword>
                <ce:text>Prognosis.</ce:text>
            </ce:keyword>
        </ce:keywords>
    </head>
    <body>
        <ce:sections>
            <ce:section>
                <ce:label>1</ce:label>
                <ce:section-title>Introduction</ce:section-title>
                <ce:para>Transient silent myocardial ischemia is a frequent and important prognostic phenomenon in coronary heart disease. Many studies have shown that occurrence of unfavourable
                    myocardial events in patients with a stable <ce:cross-refs refid="BIB1 BIB2 BIB3">[1&#x2013;3]</ce:cross-refs> or unstable angina pectoris <ce:cross-refs
                        refid="BIB4 BIB5 BIB6 BIB7">[4&#x2013;7]</ce:cross-refs> was significantly correlated with the presence of silent ischemia.</ce:para>
                <ce:para>Many of the studies conducted to date, evaluating the clinical value of silent ischemiaafter an acute myocardial infarction, stem from either the pre-thrombolytic era
                        <ce:cross-refs refid="BIB8 BIB9 BIB10 BIB11">[8&#x2013;11]</ce:cross-refs> or included only those patients that were treated in a conservative manner <ce:cross-ref
                        refid="BIB12">[12]</ce:cross-ref>. More recent studies have evaluated both the conventionally treated patients as well as those receiving thrombolytic therapy <ce:cross-refs
                        refid="BIB13 BIB14 BIB15 BIB16 BIB17 BIB18">[13&#x2013;18]</ce:cross-refs>. Furthermore only a few studies have been carried out on infarct patients who underwent exclusively
                    thrombolytic treatment thereby considering influence of thrombolysis on the incidence of silent ischemia after myocardial infarction <ce:cross-refs refid="BIB19 BIB20"
                        >[19,20]</ce:cross-refs>. This question is of particular importance from the point of view of reocclusion after thrombolysis <ce:cross-ref refid="BIB21">[21]</ce:cross-ref>.
                    The available data are variable and in part controversial due to the heterogeneous collection of patients studied.</ce:para>
                <ce:para>The objective of the present study was to investigate, if silent ischemia detected by 24 h-Holter-monitoring in patients, who all had received thrombolytic therapy for acute
                    myocardial infarction or thrombolysis and additional delayed early percutaneous transluminal coronary angioplasty of the infarct-related artery if indicated, gave evidence of
                    predictive value in terms of in-hospital and long-term outcome.</ce:para>
            </ce:section>
            <ce:section>
                <ce:label>2</ce:label>
                <ce:section-title>Methods</ce:section-title>
                <ce:section>
                    <ce:label>2.1</ce:label>
                    <ce:section-title>Study population</ce:section-title>
                    <ce:para>Between March 1990, and January 1992, 126 consecutive patients were included in the study (18&#x003C;age&#x003C;75 years). The inclusion criteria were as follows: (1). a
                        working preliminary diagnosis of &#x2018;&#x2018;acute myocardial infarction&#x201D; based on history of clinical symptoms and &#x2265;0.1 mV ST elevation in at least one
                        standard or two precordial electrocardiogram (ECG) leads, (2) admission to intensive care unit within 4 h of onset of symptoms and (3) lack of contraindications for
                        thrombolytic therapy.</ce:para>
                    <ce:para>A myocardial infarction was considered as definite when the level of serum creatine kinase in two successive measurements was more than 25% over the upper limit of the
                        normal range of the admitting hospital and both clinical symptoms and ECG recordings pointed to an acute myocardial infarction as described previously <ce:cross-ref
                            refid="BIB22">[22]</ce:cross-ref>. If the creatine kinase elevations did not occur, patients were excluded from the study.</ce:para>
                    <ce:para>The here described investigation was carried out as substudy of a randomized prospective multi-hospital study, termed Southwest German Interventional Study in Acute
                        Myocardial Infarction (SIAM), Part II <ce:cross-ref refid="BIB22">[22]</ce:cross-ref>, in which 14 hospitals participated. In this investigation the enrolled patients were
                        grouped according to the study protocol, in order to compare a conservative with an invasive strategy after thrombolysis with anistreplase (anisoylated plasminogen
                        streptokinase activator complex) in acute myocardial infarction <ce:cross-refs refid="BIB22 BIB23">[22,23]</ce:cross-refs>. The conservative strategy consisted of no coronary
                        angiography or percutaneous transluminal coronary angioplasty during the first 21 days, with coronary angiography performed only before discharge. The patient cohort we
                        analyzed represented the patients of the &#x201C;invasive group&#x201C; who were transferred to our hospital and underwent early coronary angiography including percutaneous
                        transluminal coronary angioplasty, if indicated, as well as pre-discharge angiography as control.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>2.2</ce:label>
                    <ce:section-title>Therapeutic regimen of acute myocardial infarction</ce:section-title>
                    <ce:para>All patients received a standard regimen as follows: anistreplase (30 mg over 5 min) in the primary hospitals within 4 h of admission. Heparin i.v. was administered 2 h
                        after onset of thrombolytic therapy, increasing the partial thromboplastin time to between 60 and 80 s. Supplementary treatment with nitroglycerine i.v. was also recommended.
                        The prophylactic use of &#x03B2;-blocker, calcium antagonists or angiotensin-converting enzyme inhibitors was not generally applied, but individually considered.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>2.3</ce:label>
                    <ce:section-title>Coronary angiography and percutaneous transluminal coronary angioplasty</ce:section-title>
                    <ce:para>Following thrombolytic treatment in the admitting primary hospitals, the patients were transferred to our intensive care unit, under continuous heparin- and nitroglycerine
                        infusion. Coronary and left ventricular angiography was performed in all patients within 14&#x2013;48 h after thombolysis in order to assess coronary status and left
                        ventricular ejection fraction. Coronary heart disease was diagnosed when the diameter of a main coronary heart vessel (left anterior descending coronary artery, left circumflex
                        coronary artery, right coronary artery, left main coronary artery) was found to be reduced by &#x2265;50%. The infarct-related artery was determined on the basis of the
                        electrocardiographic infarct site, the coronary lesion, and motility pattern of the left ventricular wall. According to the study protocol, percutaneous transluminal coronary
                        angioplasty was performed when a diameter reduction of <math altimg="si1.gif"><rm><unl type="bar">></unl></rm></math>70% in the infarct-related artery was established by
                        eyeball estimation of the operator, and the location and morphology of the stenosis were appropriate. percutaneous transluminal coronary angioplasty was considered successful,
                        if a residual stenosis of &#x2264;30% could be achieved. The degree of coronary heart disease was assessed due to the coronary status after percutaneous transluminal coronary
                        angioplasty.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>2.4</ce:label>
                    <ce:section-title>Holter-monitoring</ce:section-title>
                    <ce:para>Following coronary diagnostics, all patients irrespective of a performed percutaneous transluminal coronary angioplasty, underwent continuous 24 h-Holter-monitoring in the
                        intensive care unit 40&#x00B1;11 hours (m&#x00B1;SD) after onset of chest pain to analyze for changes in the ST-segment. The 24 h-ECG recording was performed with an amplitude
                        modulated dual channel system <ce:cross-ref refid="BIB24">[24]</ce:cross-ref>, the Tracker-recorder (Reynolds medical), using high quality pre-gelled electrodes (Blue-Sensor,
                        Medicotest A/S Denmark) and the leads CM-V5 and CC-V5 <ce:cross-ref refid="BIB25">[25]</ce:cross-ref>. All patients were given tranquilizers and/or analgetics and remained in a
                        supine position during the whole recording period. Analysis of the magnetic tapes (TDK) for ST-segment changes was carried out using a commercially available computerized
                        system (Pathfinder 4, Reynolds medical).</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>2.5</ce:label>
                    <ce:section-title>Definition of a ST-episode</ce:section-title>
                    <ce:para>A significant ischemic ST-episode was defined as a ST-segment elevation or planar/downsloping ST-depression of &#x2265;1 mm measured at 60&#x2013;80 ms beyond the
                        individually fixed J point, lasting for at least 1 min. An interval of &#x2265;1 min was required between two distinct ST-episodes. The reference point for each ST-episode was
                        individually fixed <ce:cross-ref refid="BIB21">[21]</ce:cross-ref>. Where there was a pre-existing ST-elevation or depression of &#x2265;0.5 mm, an additional ST-segment
                        elevation or depression of &#x2265;1 mm, respectively, was considered as a significant ST-change from baseline.</ce:para>
                    <ce:para>Print-outs at a velocity of 25 mm/s of the beginning, the maximal ST-segment deviation and the end of each ST-episode were visually controlled by means of QRS-complex
                        form-analysis <ce:cross-ref refid="BIB26">[26]</ce:cross-ref>, and the ST-changes were re-checked to avoid false positive results. Each ST-episode was visually controlled by
                        two independent observers experienced in ST-segment analysis and blinded to the clinical and angiographical data and follow-up of the patients. Differences were resolved by
                        consensus.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>2.6</ce:label>
                    <ce:section-title>Cardiac events</ce:section-title>
                    <ce:para>As primary endpoints the non-fatal cardiac events (nonfatal reinfarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting) as well as
                        cardiac death were used. Cardiac events were documented in all patients during the in-hospital phase and during a long-term follow-up of 3 years after acute myocardial
                        infarction in those patients without any cardiac event prior to discharge. Elective percutaneous transluminal coronary angioplasty or coronary artery bypass grafting were not
                        taken as primary endpoints. Thereafter, the cardiac events, particularly in the case of absentee patients, were documented by means of a telephone interview or from the
                        attending general practitioner.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>2.7</ce:label>
                    <ce:section-title>Statistical methods</ce:section-title>
                    <ce:para>Continuous data are given as mean&#x00B1;SD and categorical data as relative frequencies. Comparison between groups were made using Student`s unpaired
                            <ce:italic>t</ce:italic>-test for continuous variables and chi-square or Fisher exact test, where appropriate, for categorical data. Cardiac event free probability was
                        estimated by the Kaplan-Meier analysis, and the cardiac event free curves of both groups were compared to each other by the log-rank test (Cox-Mantel). A
                            <ce:italic>p</ce:italic>-value &#x003C;0.05 was accepted as significant. The prognostic value of silent ischemia in comparison to that of left ventricular ejection fraction
                        &#x003C;40% was assessed by calculating sensitivity (true positive/true positive+false negative), specificity (true negative/true negative+false positive), and positive (true
                        positive/true positive+false positive) and negative predictive accuracy (true negative/true negative+false negative).</ce:para>
                </ce:section>
            </ce:section>
            <ce:section>
                <ce:label>3</ce:label>
                <ce:section-title>Results</ce:section-title>
                <ce:section>
                    <ce:label>3.1</ce:label>
                    <ce:section-title>Patients</ce:section-title>
                    <ce:para>Of the 126 consecutive patients who underwent Holter-monitoring, a total of 29 patients were excluded for the following reasons: no definite diagnosis for acute myocardial
                        infarction (<ce:italic>n</ce:italic>=13), poor quality of the long-term ECG-recordings (<ce:italic>n</ce:italic>=5), left bundle branch block (<ce:italic>n</ce:italic>=3),
                        intermittent atrial fibrillation (<ce:italic>n</ce:italic>=2), premature discontinuation of the 24 h-ECG-monitoring because of cerebral haemorrhage as well as a requirement for
                        blood transfusion due to retroperitonial bleeding (<ce:italic>n</ce:italic>=2), reinfarction or reocclusion syndrome during ECG-recording with symptomatic ST-episodes of
                        ischemia (<ce:italic>n</ce:italic>=4).</ce:para>
                    <ce:para>The remaining 97 eligible patients (85 men, 12 women, mean age 57&#x00B1;9, range 21&#x2013;75 years) were included in the study for further investigation and data
                        analysis. In 10 of the 97 patients (10%), silent ST-episodes were detected on Holter-monitoring (group A), 87 patients exhibited no significant ST-segment depression (group B).
                            <ce:cross-ref refid="TBL1">Table 1</ce:cross-ref><ce:float-anchor refid="TBL1"/> shows the clinical baseline characteristics of the patients. Both groups were comparable in
                        terms of age, sex, location of myocardial infarction, and coronary risk factors. Strikingly, the peak creatine kinase value was 68% higher, and there was a more than two-fold
                        higher rate of previous acute myocardial infarction in group A, however, without reaching statistical significance. Furthermore, group A patients showed a trend towards a lower
                        left ventricular ejection fraction (<ce:italic>p</ce:italic>=0.07). There were no differences in the additional individually administered anti-anginous therapy between the two
                        patient groups.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>3.2</ce:label>
                    <ce:section-title>Angiographic data and frequency of percutaneous transluminal coronary angioplasty</ce:section-title>
                    <ce:para>Group A patients showed less an 0-vessel disease (all stenoses &#x003C;50%) and more frequently a three-vessel disease than group B patients at the time of 24
                        h-ECG-monitoring, but these differences did not reach statistical significance. The incidence of 1-or 2-vessel disease were comparable between the groups. In 5/10 patients with
                        silent ischemia each, either a 0&#x2013;1-vessel or a 2&#x2013;3-vessel disease was documented. Further in both groups an equal number of patients had undergone previous
                        percutaneous transluminal coronary angioplasty. Percutaneous transluminal coronary angioplasty of the infarct-related artery with a stenosis of &#x2265;70% was successful
                        (residual stenosis &#x2264;30%) in all cases (<ce:italic>n</ce:italic>=57), but one. This patient was counted among those patients without percutaneous transluminal coronary
                        angioplasty (<ce:italic>n</ce:italic>=40). The incidence of silent ischemia in patients with and without percutaneous transluminal coronary angioplasty did not differ from each
                        other (6/57 (11%) vs. 4/40 (10%), NS) The angiographically determined left ventricular ejection fraction showed borderline lower values for group A in comparison to group B,
                        that were not significant. When differentiated according to a reduced left ventricular ejection fraction, a higher proportion of patients in the group with silent ischemia
                        showed a left ventricular ejection fraction &#x003C;40% without reaching significance (<ce:cross-ref refid="TBL2">Table 2</ce:cross-ref><ce:float-anchor refid="TBL2"
                        />).</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>3.3</ce:label>
                    <ce:section-title>Holter-monitoring</ce:section-title>
                    <ce:para>There were no significant differences between the two groups regarding the mean duration time of the 24 h-ECGs and the length of time involved between the onset of
                        symptoms and start of Holter-monitoring. The 10 patients with silent ischemia had a total of 42 ST-episodes lasting for 401 min, that is 4.2 episodes per patient with an
                        average duration per patient of 40 min. The average duration of individual episodes was found to be 9.5 min. The mean ST-segment deviation per episode was 1.4 mm, the maximum
                        deviation between 1.1 and 3.3 mm (<ce:cross-ref refid="TBL3">Table 3</ce:cross-ref><ce:float-anchor refid="TBL3"/>).</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>3.4</ce:label>
                    <ce:section-title>In-hospital phase</ce:section-title>
                    <ce:para>During the in-hospital phase (27&#x00B1;3 days, mean&#x00B1;SD), 1 patient each from group A and B (1-vessel disease, left ventricular ejection fraction=31% and 2-vessel
                        disease, left ventricular ejection fraction=21%, respectively) suffered a fatal myocardial infarction (10% vs. 1%, <ce:italic>p</ce:italic>&#x003C;0.05). A second patient in
                        group A died of cerebral hemorrhage (0-vessel disease, left ventricular ejection fraction=54%). In group B another patient suffered a non-fatal myocardial reinfarction
                            (<ce:cross-ref refid="TBL4">Table 4</ce:cross-ref><ce:float-anchor refid="TBL4"/>).</ce:para>
                    <ce:para>A total of 26 elective percutaneous transluminal coronary angioplasties, 2/10 (20%) in group A vs. 24/87 (28%) in group B, were performed according to morphological
                        findings in the control angiography at week 4 after acute myocardial infarction and not due to any new angina pectoris symptoms. Emergency revascularizations (percutaneous
                        transluminal coronary angioplasty or coronary artery bypass grafting) were not necessary. Further, there were no differences between the 2 groups regarding the frequency of all
                        cardiac events (emergency percutaneous transluminal coronary angioplasty or coronary artery bypass grafting, non fatal reinfarction, and cardiac death).</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>3.5</ce:label>
                    <ce:section-title>Long-term follow-up</ce:section-title>
                    <ce:para>The follow-up period extended over 3 years (923&#x00B1;389 days) after discharge from the hospital. There was no significant disparity between the groups A and B regarding
                        the length of the follow-up period (727&#x00B1;608 vs. 944&#x00B1;354 days, mean&#x00B1;SD, NS). Moreover no patients were lost to follow-up on grounds of an unknown change of
                        domicile, so that data from all patients were obtained.</ce:para>
                    <ce:para>By log-rank test the cardiac mortality rate during long-term follow-up was significantly higher in group A patients than in group B (25% vs. 5%,
                        <ce:italic>p</ce:italic>&#x003C;0.02). The death of the group A patient from a non-cardiac event, actually resulted from multiple organ failure after coronary artery bypass
                        grafting (3-vessel disease, left ventricular ejection fraction=25%). Similarly, in group B, the death of a patient after 875 days was due to a non-cardiac event (2-vessel
                        disease, left ventricular ejection fraction=37%). Further statistically there were no significant differences between the two groups with respect to non fatal reinfarctions,
                        emergency percutaneous transluminal coronary angioplasty or coronary artery bypass grafting, and the incidence of all cardiac events together. The indication for performing a
                        coronary artery bypass grafting was based on the coronary status of the initial angiography and not on the results of ST-segment analysis (<ce:cross-ref refid="TBL4">Table
                            4</ce:cross-ref>).</ce:para>
                    <ce:para>Considering the total observation time after acute myocardial infarction (in-hospital phase and long-term follow-up, 950&#x00B1;392 days, mean&#x00B1;SD), once again, our
                        results show a fivefold mortality rate in group A (30% vs. 6%, <ce:italic>p</ce:italic>&#x003C;0.01 by log-rank test). Referring to the incidence of non-fatal reinfarctions,
                        emergency revascularizations and all cardiac events together, during the total study time as well as during the 2 separate study periods taken alone, we were unable to find any
                        significant differences between group A and B (<ce:cross-refs refid="FIG1 FIG2">Figs. 1 and 2</ce:cross-refs><ce:float-anchor refid="FIG1"/><ce:float-anchor refid="FIG2"
                        />).</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>3.6</ce:label>
                    <ce:section-title>Relationship between silent ischemia, reduced left ventricular ejection fraction and cardiac mortality</ce:section-title>
                    <ce:para>It is noteworthy that all three patients in group A whose death resulted from a cardiac event, showed a left ventricular ejection fraction &#x003C;40%. A fourth patient
                        with a left ventricular ejection fraction of 25% suffered fatal multiple organ failure after coronary artery bypass grafting on day 44 after acute myocardial
                        infarction.</ce:para>
                    <ce:para>The highest sensitivity was calculated for a left ventricular ejection fraction &#x003C;40% (75%), the highest positive predictive value for the simultaneous occurrence of
                        silent ischemia and left ventricular ejection fraction &#x003C;40% (75%). The specificity and the negative predictive value for both risk parameters was found to be high, alone
                        as well as together (<ce:cross-ref refid="TBL5">Table 5</ce:cross-ref><ce:float-anchor refid="TBL5"/>).</ce:para>
                    <ce:para>There was no significant relationship between the number and duration of ST-segment changes, qualitative characteristic features such as maximal elevation and depression
                        of the ST-segment, and the incidence of cardiac death.</ce:para>
                </ce:section>
            </ce:section>
            <ce:section>
                <ce:label>4</ce:label>
                <ce:section-title>Discussion</ce:section-title>
                <ce:para>Recurrent myocardial ischemia, either silent or symptomatic, early after acute myocardial infarction in patients all treated by thrombolysis is associated with an increased
                    risk of unfavourable cardiac events <ce:cross-refs refid="BIB19 BIB20">[19,20]</ce:cross-refs>. However, the incidence and predictive value of silent ischemia after thrombolysis
                    and early interventional therapy has not been investigated yet. In the present study, we have demonstrated in a small selected group of young infarct patients, by means of 24
                    h-Holter-ECGs performed during the early postinfarction period, that silent ischemia was even present after thrombolysis and early delayed percutaneous transluminal coronary
                    angiopalsty in 10% of patients indicating either a residual ischemia in the infarcted zone despite a combined reperfusion therapy or a remote ischemic potential in 5/10 patients
                    (50%) with 2 or 3-vessel disease, as Stevenson et al. <ce:cross-ref refid="BIB27">[27]</ce:cross-ref> recently discussed in infarct patients treated by thrombolysis. Further, by
                    Kaplan Meier analysis, silent ischemia was significantly associated with cardiac death during the in-hospital phase and the 3-year follow-up.</ce:para>
                <ce:section>
                    <ce:label>4.1</ce:label>
                    <ce:section-title>Incidence</ce:section-title>
                    <ce:para>The relatively low incidence of 10% for silent ischemia in our study lies almost at the lower boundaries, when compared to other reports in which myocardial ischemia
                        following myocardial infarction is described in 8 to 46% of the patients <ce:cross-refs refid="BIB8 BIB9 BIB10 BIB11 BIB12 BIB13 BIB14 BIB15 BIB16 BIB17 BIB18 BIB19 BIB20"
                            >[8&#x2013;20]</ce:cross-refs>. This may be attributed to the following factors: (1) standard thrombolytic therapy and early delayed percutaneous transluminal coronary
                        angioplasty of the infarct vessel, if indicated, in relatively young patients (mean age 57&#x00B1;10, range 21&#x2013;75 years), to minimize the risk of ischemia after
                        myocardial infarction, (2) early start of 24 h-Holter-monitoring (40&#x00B1;11 h after onset of symptoms), and (3) taking into consideration only silent ST-episodes for further
                        analysis in this study. Furthermore, the patients were sedated and in bed during the total observation time for SI. Often silent ST-episodes are provoked by silent increases in
                        heart rate and blood pressure which were likely reduced by the type of therapy these patients received.</ce:para>
                    <ce:para>In the collectives by Silva et al. <ce:cross-ref refid="BIB19">[19]</ce:cross-ref> and Stevenson et al. <ce:cross-ref refid="BIB20">[20]</ce:cross-ref> who describe
                        Holter-detected ST-episodes after acute mycardial infarction in 8 or 41%, respectively, a thrombolytic therapy was received by all the patients, although the distribution of
                        the thrombolytic agents streptokinase and alteplase was dissimilar in the 2 studies. Other authors <ce:cross-refs refid="BIB9 BIB10 BIB11">[9&#x2013;11]</ce:cross-refs> either
                        make no comments regarding thrombolytic treatment or have not included patients undergoing thrombolytic therapy <ce:cross-ref refid="BIB12">[12]</ce:cross-ref>. In many of the
                        current reports the proportion of patients receiving fibrinolytic therapy ranged from 18 to 78% <ce:cross-refs refid="BIB13 BIB15 BIB16 BIB17 BIB18"
                            >[13,15&#x2013;18]</ce:cross-refs>. Surprisingly, there was no evidence of any significant relation between the thrombolytic therapy and the occurence of transient
                        myocardial ischemia.</ce:para>
                    <ce:para>We chose to record silent so early after acute myocardial infarction in order to identify those asymptomatic patients particularly at risk, so that prompt invasive
                        diagnostics and treatment could be undertaken <ce:cross-ref refid="BIB28">[28]</ce:cross-ref>. According to the results from Currie et al. <ce:cross-ref refid="BIB9"
                            >[9]</ce:cross-ref>, silent ischemia early after myocardial infarction is prognostically more significant, although its presence in the subacute phase of myocardial
                        infarction is less frequent than in the subsequent weeks.</ce:para>
                    <ce:para>Like other investigators <ce:cross-refs refid="BIB12 BIB15 BIB16 BIB18 BIB19">[12,15,16,18,19]</ce:cross-refs>, we could not find any significant correlation between the
                        occurrence of early transient myocardial ischemia on Holter-monitoring and clinical baseline characteristics, including the history and the location and size of myocardial
                        infarction. Our data showed that, after successful percutaneous transluminal coronary angioplasty, there were more patients with 3-vessel disease (30% vs. 8%) and less with
                        0-vessel disease (diameter reduction &#x003C;50%; 10% vs. 30%) in the group with silent ischemia. However, these differences were not significant because of the small sample
                        size of patients with silent ischemia. Both Solimene et al. <ce:cross-ref refid="BIB12">[12]</ce:cross-ref> and Silva et al. <ce:cross-ref refid="BIB19">[19]</ce:cross-ref>
                        found a significant relationship between the incidence of transient myocardial ischemia and the higher frequency of multi-vessel disease <ce:cross-refs refid="BIB12 BIB19"
                            >[12,19]</ce:cross-refs> or the slighter occurrence of an 0/1-vessel disease <ce:cross-ref refid="BIB19">[19]</ce:cross-ref>, respectively.</ce:para>
                    <ce:para>We did not find any difference in silent ischemia between the patients with and those without percutaneous transluminal coronary angioplasty, which could not be expected
                        according to the study protocol, since the decision to perform a percutaneous transluminal coronary angioplasty was not based on randomization, but on the presence of a
                        diameter reduction in the infarct-related artery of &#x2265;70% with appropriate morphology and location. Thus, it was not possible to investigate the influence of early
                        interventional revascularization following thrombolysis on silent ischemia in the subacute phase of myocardial infarction.</ce:para>
                    <ce:para>The left ventricular ejection fraction as assessed by left ventricular angiography showed lower values in group A based on the larger infract size and the higher rate of
                        previous myocardial infarction, without however achieving statistical significance (<ce:italic>p</ce:italic>=0.07) due to the small number of the patients. Many other authors
                            <ce:cross-refs refid="BIB12 BIB14 BIB15 BIB16 BIB19">[12,14&#x2013;16,19]</ce:cross-refs> found no significant differences in the value for left ventricular ejection
                        fraction either between patients with and those without transient myocardial ischemia.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>4.2</ce:label>
                    <ce:section-title>Silent ischemia and left ventricular ejection fraction</ce:section-title>
                    <ce:para>The observation that 40% of the patients with SI also had a left ventricular ejection fraction &#x003C;40% is in good agreement with experimental data concerning the
                        consequences of prolonged myocardial ischemia on left ventricular function. A relationship between recurring ischemia and left ventricular dysfunction is exhibited in the form
                        of a so-called &#x201C;stunned myocardium&#x201D; <ce:cross-ref refid="BIB29">[29]</ce:cross-ref>. Moreover, the work of Langer et al. <ce:cross-ref refid="BIB15"
                            >[15]</ce:cross-ref> also underlines that a significant improvement of left ventricular ejection fraction within 9 days following myocardial infarction has been seen in
                        patients without silent ischemia in the first postinfarction week, in comparison to those patients with silent ischemia indicating that the presence of transient ischemia after
                        acute myocardial infarction represents a prognostic factor for the recovery of left ventricular ejection fraction.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>4.3</ce:label>
                    <ce:section-title>In-hospital phase</ce:section-title>
                    <ce:para>Our data show a higher rate of cardiac mortality in group A, though only one patient died in group A and 1 in group B. Due to this low event rate, the cardiac mortality of
                        patients with and without silent ischemia during hospitalization needs to be evaluated with caution. There appears to be no significant difference in the number of non-fatal
                        reinfarctions, emergency percutaneous transluminal coronary angioplasties/coronary artery bypass graftings, and all cardiac events together between the two patient groups
                        during the in-hospital phase.</ce:para>
                    <ce:para>The results from other investigators are controversial with regard to the in-hospital phase: Silva et al. <ce:cross-ref refid="BIB19">[19]</ce:cross-ref> observed a
                        significantly higher risk of reinfarctions and emergency revascularizations when ischemia was present during 24 h-ECG-monitoring, though the rate of mortality and elective
                        revascularization were not thereby affected. Langer and co-workers <ce:cross-ref refid="BIB15">[15]</ce:cross-ref>, on the other hand, could not establish any differences
                        regarding cardiac events during hospitalization.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>4.4</ce:label>
                    <ce:section-title>Long-term follow-up</ce:section-title>
                    <ce:para>In the present study, a cardiac mortality rate of 5% was determined during the 3-year follow-up after discharge for group B, whereas patients in group A showed a fivefold
                        mortality rate (25% vs. 5%). This trend remained constant for group A patients regarding the cardiac mortality (30% vs. 6%) during total observation time (hospitalization and
                        long-term follow-up). Since patients with ST-episodes also had a lower left ventricular ejection fraction (<ce:italic>p</ce:italic>=0.07), the higher mortality rate in this
                        group has to be reasonably attributed to both early recurrent myocardial ischemia and left ventricular dysfunction. Further, it must be emphasized that the cardiac death was
                        also closely associated with a left ventricular ejection fraction &#x003C;40%, having even a higher sensitivity than the presence of SI, which is in agreement with the
                        established predictive value of a reduced left ventricular ejection fraction after myocardial infarction <ce:cross-ref refid="BIB30">[30]</ce:cross-ref>. When both silent
                        ischemia and left ventricular ejection fraction &#x003C;40% occur simultaneously, a group at high risk for cardiac death (<ce:italic>p</ce:italic>=0.001) can be identified with
                        the highest specificity and positive predictive value. In the prethrombolytic era, Gottlieb and co-workers <ce:cross-ref refid="BIB10">[10]</ce:cross-ref> found in a group of
                        high-risk postinfarction patients (left ventricular ejection fraction &#x003C;40% and/or Lown ventricular class III or higher) a significant relationship between silent
                        ischemia and an increased 1-year-mortality rate which was independent of left ventricular ejection fraction and the post-mortem coronary findings. Recently, Gill et al.
                            <ce:cross-ref refid="BIB13">[13]</ce:cross-ref> demonstrated that the positive predictive value of transient ischemia for death after myocardial infarction was low (12%)
                        and left ventricular ejection fraction the stronger indicator for death after 1 year, though myocardial ischemia provided important prognostic information for other events such
                        as non-fatal myocardial infarction and unstable angina pectoris.</ce:para>
                    <ce:para>The incidence of non-fatal (non-fatal reinfarctions and emergency percutaneous transluminal coronary angioplasty or coronary artery bypass grafting) and all cardiac events
                        together (non-fatal reinfarctions, emergency percutaneous transluminal coronary angioplasty or coronary artery bypass grafting, and cardiac death) were not statistically
                        different between the groups A and B due to the small number of events. Gill and co-workers <ce:cross-ref refid="BIB13">[13]</ce:cross-ref> found a 2.3-to 3-fold rate of
                        non-fatal coronary events and death during a follow-up period over 1 year in postinfarction patients receiving thrombolytic therapy in 55%. Similarly, in two recent studies
                            <ce:cross-refs refid="BIB19 BIB20">[19,20]</ce:cross-refs> including only infarct patients treated with thrombolytic agents the patients with transient myocardial ischemia
                        in the early post-thrombolysis phase were found to have an increased risk of fatal and non-fatal reinfarctions particularly within the first 30 days after acute myocardial
                        infarction <ce:cross-ref refid="BIB20">[20]</ce:cross-ref> or more in-hospital non-fatal coronary events, respectively <ce:cross-ref refid="BIB19">[19]</ce:cross-ref>. In the
                        former study <ce:cross-ref refid="BIB19">[19]</ce:cross-ref>, a significant decrease in survival without reinfarction and survival without combined cardiac events could be
                        shown by Kaplan Meier analysis during a 6-month follow-up in patients having transient myocardial ischemia early after myocardial infarction.</ce:para>
                </ce:section>
                <ce:section>
                    <ce:label>4.5</ce:label>
                    <ce:section-title>Limitations</ce:section-title>
                    <ce:para>In comparison to other studies concerning the significance of transient myocardial ischemia after thrombolytic therapy for acute myocardial infarction <ce:cross-refs
                            refid="BIB19 BIB20">[19,20]</ce:cross-refs>, both the number of patients and cardiac events in our study are markedly lower, and thus, the clinical significance of the
                        present data is quite limited. Moreover, the patient collective studied consisted of individuals with a relatively low mean age who had early percutaneous transluminal coronary
                        angioplasty performed after acute myocardial infarction treated by thrombolysis, thus selecting out a small low-risk group from the total number of infarct patients. This makes
                        the interpretation of the results difficult and precludes its generalization to all infarct patients. Nevertheless, the findings tend to be in agreement with many previous
                        studies dealing with the prognostic value of silent after acute myocardial from both the pre-thrombolytic and thrombolytic era <ce:cross-refs
                            refid="BIB13 BIB14 BIB15 BIB16 BIB17 BIB18 BIB19 BIB20">[13&#x2013;20]</ce:cross-refs>.</ce:para>
                    <ce:para>In summary, our data show that, after acute myocardial infarction treated with thrombolytic therapy followed by early delayed percutaneous transluminal coronary
                        angioplasty, about a tenth of the patients have silent ischemia in the early postinfarction period indicating either a residual ischemia in the infarcted zone despite a
                        combined reperfusion strategy or a remote ischemic potential in case of multivessel disease. These patients showed a tendency towards a lower left ventricular ejection fraction
                        and a higher cardiac mortality than patients without silent ischemia. When both silent ischemia as well as left ventricular ejection fraction &#x003C;40% were present, the
                        combination of these two parameters identified a patient group at high risk for cardiac death with a high positive predictive value during a 3-year follow-up.</ce:para>
                    <ce:para>From these results it is concluded that silent ischemia in the subacute phase of myocardial infarction after thrombolysis and early coronary intervention is to be
                        considered as an important non-invasive prognostic parameter taken alone, and when occurring in the presence of a reduced left ventricular ejection fraction, provides valuable
                        additional information for long-term prognosis following acute myocardial infarction.</ce:para>
                </ce:section>
            </ce:section>
        </ce:sections>
        <ce:acknowledgment>
            <ce:section-title>Acknowledgements</ce:section-title>
            <ce:para>We are grateful to Mrs Birgit Lotze for her help in the preparation of the manuscript.</ce:para>
        </ce:acknowledgment>
    </body>
    <tail>
        <ce:bibliography>
            <ce:section-title>References</ce:section-title>
            <ce:bibliography-sec>
                <ce:bib-reference id="BIB1">
                    <ce:label>[1]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>P.C.</ce:given-name>
                                    <ce:surname>Deedwania</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>E.V.</ce:given-name>
                                    <ce:surname>Carbajal</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Silent ischemia during daily life is an independent predictor of mortality in stable angina</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Circulation</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>81</sb:volume-nr>
                                </sb:series>
                                <sb:date>1990</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>748</sb:first-page>
                                <sb:last-page>756</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB2">
                    <ce:label>[2]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>M.B.</ce:given-name>
                                    <ce:surname>Rocco</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>E.G.</ce:given-name>
                                    <ce:surname>Nabel</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.</ce:given-name>
                                    <ce:surname>Campbell</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>L.</ce:given-name>
                                    <ce:surname>Goldman</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>J.</ce:given-name>
                                    <ce:surname>Barry</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>K.</ce:given-name>
                                    <ce:surname>Mead</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prognostic importance of myocardial ischemia by ambulatory monitoring in patients with stable coronary artery disease</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Circulation</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>78</sb:volume-nr>
                                </sb:series>
                                <sb:date>1988</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>877</sb:first-page>
                                <sb:last-page>884</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB3">
                    <ce:label>[3]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Tzivoni</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>G.</ce:given-name>
                                    <ce:surname>Weisz</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>A.</ce:given-name>
                                    <ce:surname>Gavish</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Zin</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>A.</ce:given-name>
                                    <ce:surname>Keren</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.</ce:given-name>
                                    <ce:surname>Stern</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Comparison of mortality and myocardial infarction rates in stable angina pectoris with and without ischemic episodes during daily
                                    activities</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>63</sb:volume-nr>
                                </sb:series>
                                <sb:date>1989</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>273</sb:first-page>
                                <sb:last-page>276</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB4">
                    <ce:label>[4]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>S.O.</ce:given-name>
                                    <ce:surname>Gottlieb</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.L.</ce:given-name>
                                    <ce:surname>Weisfeldt</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>P.</ce:given-name>
                                    <ce:surname>Ouyang</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>E.D.</ce:given-name>
                                    <ce:surname>Mellits</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>G.</ce:given-name>
                                    <ce:surname>Gerstenblith</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>N Engl J Med</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>314</sb:volume-nr>
                                </sb:series>
                                <sb:date>1986</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>1214</sb:first-page>
                                <sb:last-page>1219</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB5">
                    <ce:label>[5]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>S.O.</ce:given-name>
                                    <ce:surname>Gottlieb</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.L.</ce:given-name>
                                    <ce:surname>Weisfeldt</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>P.</ce:given-name>
                                    <ce:surname>Ouyang</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>E.D.</ce:given-name>
                                    <ce:surname>Mellits</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>G.</ce:given-name>
                                    <ce:surname>Gerstenblith</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Silent ischemia predicts infarction and death during 2 year follow-up in unstable angina</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>J Am Coll Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>10</sb:volume-nr>
                                </sb:series>
                                <sb:date>1987</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>756</sb:first-page>
                                <sb:last-page>760</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB6">
                    <ce:label>[6]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>K.</ce:given-name>
                                    <ce:surname>Nademanee</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>V.</ce:given-name>
                                    <ce:surname>Intarachot</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.A.</ce:given-name>
                                    <ce:surname>Josephson</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Rieders</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>F.V.</ce:given-name>
                                    <ce:surname>Mody</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.N.</ce:given-name>
                                    <ce:surname>Singh</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prognostic significance of silent myocardial ischemia in patients with unstable angina</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>J Am Coll Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>10</sb:volume-nr>
                                </sb:series>
                                <sb:date>1987</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>1</sb:first-page>
                                <sb:last-page>9</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB7">
                    <ce:label>[7]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>T.</ce:given-name>
                                    <ce:surname>Von Arnim</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>H.W.</ce:given-name>
                                    <ce:surname>Gerbig</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>W.</ce:given-name>
                                    <ce:surname>Krawietz</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.</ce:given-name>
                                    <ce:surname>H&#x00F6;fling</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prognostic implications of transient-pre-dominantly silent-ischaemia in patients with unstable angina pectoris</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Eur Heart J</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>9</sb:volume-nr>
                                </sb:series>
                                <sb:date>1988</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>435</sb:first-page>
                                <sb:last-page>440</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB8">
                    <ce:label>[8]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Bonaduce</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.</ce:given-name>
                                    <ce:surname>Petretta</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>T.</ce:given-name>
                                    <ce:surname>Lanzillo</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>G.</ce:given-name>
                                    <ce:surname>Vitagliano</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>V.</ce:given-name>
                                    <ce:surname>Bianchi</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>G.</ce:given-name>
                                    <ce:surname>Conforti</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prevalence and prognostic significance of silent myocardial ischaemia detected by exercise test and continuous ECG monitoring after acute myocardial
                                    infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Eur Heart J</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>12</sb:volume-nr>
                                </sb:series>
                                <sb:date>1991</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>186</sb:first-page>
                                <sb:last-page>193</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB9">
                    <ce:label>[9]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>P.</ce:given-name>
                                    <ce:surname>Currie</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Ashby</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.</ce:given-name>
                                    <ce:surname>Saltissi</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prognostic significance of transient myocardial ischemia on ambulatory monitoring after acute myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>71</sb:volume-nr>
                                </sb:series>
                                <sb:date>1983</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>773</sb:first-page>
                                <sb:last-page>777</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB10">
                    <ce:label>[10]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>S.O.</ce:given-name>
                                    <ce:surname>Gottlieb</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.H.</ce:given-name>
                                    <ce:surname>Gottlieb</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.C.</ce:given-name>
                                    <ce:surname>Achuff</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>R.</ce:given-name>
                                    <ce:surname>Baumgardner</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>E.D.</ce:given-name>
                                    <ce:surname>Mellits</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.L.</ce:given-name>
                                    <ce:surname>Weisfeldt</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Silent ischemia on holter monitoring predicts mortality in high-risk postinfarction patients</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>J Am Med Assoc</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>259</sb:volume-nr>
                                </sb:series>
                                <sb:date>1988</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>1030</sb:first-page>
                                <sb:last-page>1035</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB11">
                    <ce:label>[11]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Tzivoni</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>A.</ce:given-name>
                                    <ce:surname>Gavish</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Zin</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>R.G.</ce:given-name>
                                    <ce:surname>Alfieri</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.F.</ce:given-name>
                                    <ce:surname>de Oliviera</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>P.L.</ce:given-name>
                                    <ce:surname>Da Luz</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prognostic significance of ischemic episodes in patients with previous myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>62</sb:volume-nr>
                                </sb:series>
                                <sb:date>1988</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>661</sb:first-page>
                                <sb:last-page>664</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB12">
                    <ce:label>[12]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>M.C.</ce:given-name>
                                    <ce:surname>Solimene</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>J.A.R.</ce:given-name>
                                    <ce:surname>Ramires</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>C.J.</ce:given-name>
                                    <ce:surname>Gruppi</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>R.G.</ce:given-name>
                                    <ce:surname>Alfieri</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.F.</ce:given-name>
                                    <ce:surname>de Oliviera</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>P.L.</ce:given-name>
                                    <ce:surname>Da Luz</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prognostic significance of silent myocardial ischemia after a first uncomplicated myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Int J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>38</sb:volume-nr>
                                </sb:series>
                                <sb:date>1993</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>41</sb:first-page>
                                <sb:last-page>47</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB13">
                    <ce:label>[13]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>J.B.</ce:given-name>
                                    <ce:surname>Gill</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>J.A.</ce:given-name>
                                    <ce:surname>Cairns</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>R.S.</ce:given-name>
                                    <ce:surname>Roberts</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>L.</ce:given-name>
                                    <ce:surname>Constantini</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.J.</ce:given-name>
                                    <ce:surname>Sealey</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>E.F.</ce:given-name>
                                    <ce:surname>Fallen</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>N Engl J Med</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>334</sb:volume-nr>
                                </sb:series>
                                <sb:date>1996</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>65</sb:first-page>
                                <sb:last-page>70</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB14">
                    <ce:label>[14]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>M.</ce:given-name>
                                    <ce:surname>Jereczek</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Andresen</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>J.</ce:given-name>
                                    <ce:surname>Schr&#x00F6;der</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>H.</ce:given-name>
                                    <ce:surname>V&#x00F6;ller</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>T.</ce:given-name>
                                    <ce:surname>Br&#x00FC;ggemann</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>C.</ce:given-name>
                                    <ce:surname>Deutschmann</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Prognostic value of ischemia during Holter monitoring and exercise testing after acute myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>72</sb:volume-nr>
                                </sb:series>
                                <sb:date>1993</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>8</sb:first-page>
                                <sb:last-page>13</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB15">
                    <ce:label>[15]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>A.</ce:given-name>
                                    <ce:surname>Langer</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>J.</ce:given-name>
                                    <ce:surname>Minkowitz</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>P.</ce:given-name>
                                    <ce:surname>Dorian</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>L.</ce:given-name>
                                    <ce:surname>Casella</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>L.</ce:given-name>
                                    <ce:surname>Harris</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>C.H.D.</ce:given-name>
                                    <ce:surname>Morgan</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>J Am Coll Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>20</sb:volume-nr>
                                </sb:series>
                                <sb:date>1992</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>1313</sb:first-page>
                                <sb:last-page>1317</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB16">
                    <ce:label>[16]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>H.</ce:given-name>
                                    <ce:surname>Mickley</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>P.</ce:given-name>
                                    <ce:surname>Pless</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>J.R.</ce:given-name>
                                    <ce:surname>Nielsen</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>J.</ce:given-name>
                                    <ce:surname>Berning</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.</ce:given-name>
                                    <ce:surname>Moller</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Transient Myocardial ischemia after a first acute myocardial infarction and its relation to clinical characteristics, predischarge exercise testing and
                                    cardiac events at one-year follow-up</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>71</sb:volume-nr>
                                </sb:series>
                                <sb:date>1993</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>139</sb:first-page>
                                <sb:last-page>144</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB17">
                    <ce:label>[17]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>P.</ce:given-name>
                                    <ce:surname>Ouyang</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>N.C.</ce:given-name>
                                    <ce:surname>Chandra</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.O.</ce:given-name>
                                    <ce:surname>Gottlieb</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Frequency and importance of silent Myocardial ischemia identified with ambulatory electrocardiographic monotoring in the early in-hospital period after
                                    acute myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>65</sb:volume-nr>
                                </sb:series>
                                <sb:date>1990</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>267</sb:first-page>
                                <sb:last-page>270</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB18">
                    <ce:label>[18]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>M.</ce:given-name>
                                    <ce:surname>Petretta</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Bonaduce</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>V.</ce:given-name>
                                    <ce:surname>Bianchi</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>G.</ce:given-name>
                                    <ce:surname>Vitagliano</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>G.</ce:given-name>
                                    <ce:surname>Conforti</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>F.</ce:given-name>
                                    <ce:surname>Rotondi</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Characterization and prognostic significance of silent myocardial ischemia on predischarge electrocardiographic monitoring in unselected patients with
                                    myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>69</sb:volume-nr>
                                </sb:series>
                                <sb:date>1992</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>579</sb:first-page>
                                <sb:last-page>583</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB19">
                    <ce:label>[19]</ce:label>
                    <ce:other-ref>
                        <ce:textref>Silva P, Galli M, Campolo L, for the IRES (Ischemia Residua) Study Group. Prognostic significance of early ischemia after acute myocardial infarction in low-risk
                            patients. Am J Cardiol 1993;71:1142&#x2013;1147.</ce:textref>
                    </ce:other-ref>
                </ce:bib-reference>
                <ce:bib-reference id="BIB20">
                    <ce:label>[20]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>R.</ce:given-name>
                                    <ce:surname>Stevenson</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>K.</ce:given-name>
                                    <ce:surname>Ranjadalayan</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>P.</ce:given-name>
                                    <ce:surname>Wilkinson</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.</ce:given-name>
                                    <ce:surname>Marchant</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>A.D.</ce:given-name>
                                    <ce:surname>Timmis</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Assessment of Holter ST monitoring for risk stratification in patients with acute myocardial infarction treated by thrombolysis</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Br Heart J</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>70</sb:volume-nr>
                                </sb:series>
                                <sb:date>1993</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>233</sb:first-page>
                                <sb:last-page>240</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB21">
                    <ce:label>[21]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>S.G.</ce:given-name>
                                    <ce:surname>Ellis</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>E.J.</ce:given-name>
                                    <ce:surname>Topol</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.S.</ce:given-name>
                                    <ce:surname>George</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.J.</ce:given-name>
                                    <ce:surname>Kereiakes</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Debowey</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>K.N.</ce:given-name>
                                    <ce:surname>Sigmon</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Recurrent ischemia without warning. Analysis of risk factors for in-hospital events following successfull thrombolysis with intravenous tissue plasminogen
                                    activator</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Circulation</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>80</sb:volume-nr>
                                </sb:series>
                                <sb:date>1989</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>1159</sb:first-page>
                                <sb:last-page>1165</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB22">
                    <ce:label>[22]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>C.</ce:given-name>
                                    <ce:surname>&#x00D6;zbek</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>A.</ce:given-name>
                                    <ce:surname>Heisel</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.</ce:given-name>
                                    <ce:surname>Krause</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>G.</ce:given-name>
                                    <ce:surname>Berg</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.</ce:given-name>
                                    <ce:surname>Hammer</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>W.</ce:given-name>
                                    <ce:surname>Bay</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Comparison of mortality from acute myocardial infarction in patients receiving anistreplase with those not receiving thrombolysis</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>76</sb:volume-nr>
                                </sb:series>
                                <sb:date>1995</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>1103</sb:first-page>
                                <sb:last-page>1107</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB23">
                    <ce:label>[23]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>C.</ce:given-name>
                                    <ce:surname>&#x00D6;zbek</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>J.</ce:given-name>
                                    <ce:surname>Dyckmans</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.</ce:given-name>
                                    <ce:surname>Sen</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>H.</ce:given-name>
                                    <ce:surname>Schieffer</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Comparison of invasive and conservative strategies after treatment with streptokinase in acute myocardial infarction. Results of a randomised trial
                                    (SIAM)</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>J Am Coll Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>15 (Suppl. A)</sb:volume-nr>
                                </sb:series>
                                <sb:date>1990</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>63A (Abstract)</sb:first-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB24">
                    <ce:label>[24]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>L.T.</ce:given-name>
                                    <ce:surname>Sheffield</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>A.</ce:given-name>
                                    <ce:surname>Berson</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Bragg-Remschel</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>P.C.</ce:given-name>
                                    <ce:surname>Gillette</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>R.E.</ce:given-name>
                                    <ce:surname>Hermes</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>L.</ce:given-name>
                                    <ce:surname>Hinkle</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Recommendations for standards of instrumentation and practice in the use of ambulatory electrocardiography</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Circulation</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>71</sb:volume-nr>
                                </sb:series>
                                <sb:date>1985</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>626A</sb:first-page>
                                <sb:last-page>636A</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB25">
                    <ce:label>[25]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>E.</ce:given-name>
                                    <ce:surname>Hoberg</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>F.</ce:given-name>
                                    <ce:surname>Schwarz</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>U.</ce:given-name>
                                    <ce:surname>Voggenreiter</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>W.</ce:given-name>
                                    <ce:surname>Kuebler</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.</ce:given-name>
                                    <ce:surname>Kunze</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Holter monitoring before, during and after percutaneous transluminal coronary angioplasty for evaluation of high-resolution trend recordings of leads CM5
                                    and CC5 for ST-segment analysis</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am J Cardiol</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>60</sb:volume-nr>
                                </sb:series>
                                <sb:date>1987</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>796</sb:first-page>
                                <sb:last-page>800</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB26">
                    <ce:label>[26]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>H.</ce:given-name>
                                    <ce:surname>V&#x00F6;ller</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Andresen</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>T.</ce:given-name>
                                    <ce:surname>Br&#x00FC;ggemann</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.</ce:given-name>
                                    <ce:surname>Jereczek</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.</ce:given-name>
                                    <ce:surname>Becker</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>R.</ce:given-name>
                                    <ce:surname>Schr&#x00F6;der</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Transient ST segment depression during Holter monitoring: How to avoid false positive findings</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Am Heart J</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>124</sb:volume-nr>
                                </sb:series>
                                <sb:date>1992</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>622</sb:first-page>
                                <sb:last-page>629</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB27">
                    <ce:label>[27]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>R.N.</ce:given-name>
                                    <ce:surname>Stevenson</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.G.</ce:given-name>
                                    <ce:surname>Marchant</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>K.</ce:given-name>
                                    <ce:surname>Ranjadayalan</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.</ce:given-name>
                                    <ce:surname>Uthayakumar</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>A.D.</ce:given-name>
                                    <ce:surname>Timmis</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Holter ST monitoring early after acute myocardial infarction: mechanisms of ischeamia in patients treated by thrombolysis</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Br Heart J</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>70</sb:volume-nr>
                                </sb:series>
                                <sb:date>1993</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>433</sb:first-page>
                                <sb:last-page>437</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB28">
                    <ce:label>[28]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>M.</ce:given-name>
                                    <ce:surname>De Belder</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>D.</ce:given-name>
                                    <ce:surname>Shekan</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>C.</ce:given-name>
                                    <ce:surname>Pumphrey</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>B.</ce:given-name>
                                    <ce:surname>Khan</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>S.</ce:given-name>
                                    <ce:surname>Evans</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>M.</ce:given-name>
                                    <ce:surname>Rothmann</ce:surname>
                                </sb:author>
                                <sb:et-al/>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Identification of a high risk subgroup of patients with silent ischemia after myocardial infarction: a group for early therapeutic
                                    revascularization?</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Br Heart J</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>63</sb:volume-nr>
                                </sb:series>
                                <sb:date>1990</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>145</sb:first-page>
                                <sb:last-page>150</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB29">
                    <ce:label>[29]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:author>
                                    <ce:given-name>E.</ce:given-name>
                                    <ce:surname>Braunwald</ce:surname>
                                </sb:author>
                                <sb:author>
                                    <ce:given-name>R.A.</ce:given-name>
                                    <ce:surname>Kloner</ce:surname>
                                </sb:author>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>The stunned myocardium: prolonged, postischemic ventricular dysfunction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>Circulation</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>66</sb:volume-nr>
                                </sb:series>
                                <sb:date>1982</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>1146</sb:first-page>
                                <sb:last-page>1149</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
                <ce:bib-reference id="BIB30">
                    <ce:label>[30]</ce:label>
                    <sb:reference>
                        <sb:contribution>
                            <sb:authors>
                                <sb:collaboration>The Multicenter Postinfarction Research Group</sb:collaboration>
                            </sb:authors>
                            <sb:title>
                                <sb:maintitle>Risk stratification and survival after myocardial infarction</sb:maintitle>
                            </sb:title>
                        </sb:contribution>
                        <sb:host>
                            <sb:issue>
                                <sb:series>
                                    <sb:title>
                                        <sb:maintitle>N Engl J Med</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>309</sb:volume-nr>
                                </sb:series>
                                <sb:date>1983</sb:date>
                            </sb:issue>
                            <sb:pages>
                                <sb:first-page>331</sb:first-page>
                                <sb:last-page>336</sb:last-page>
                            </sb:pages>
                        </sb:host>
                    </sb:reference>
                </ce:bib-reference>
            </ce:bibliography-sec>
        </ce:bibliography>
    </tail>
</converted-article>
